RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line

Cancer Genetics and Cytogenetics

Volumn 200, Issue 2, 2010, Pages 110-119

  Ou, Liping ^a   Guo, Yongcan ^a   Luo, Chunli ^a   Wu, Xiaohou ^b   Zhao, Yi ^a   Cai, Xiaozhong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; PHOSPHOLIPASE; PHOSPHOLIPASE C EPSILON1; PROTEIN BCL 2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; NONVIRAL GENE THERAPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; URINARY BLADDER NEOPLASMS;

EID: 77953742449     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.01.021     Document Type: Article

References (28)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics. CA Cancer J Clin 2002, 2005(55):74-108.
2. Tran E., Souhami L., Tanguay S., Rajan R. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol 2009, 32:333-337.
3. Brendler C.B., Steinberg G.D., Marshall F.F., Mostwin J.L., Walsh P.C. Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol 1990, 144:1137-1140.
4. Raghavan D., Huben R. Management of bladder cancer. Curr Probl Cancer 1995, 19:1-64.
5. Frazier H.A., Robertson J.E., Dodge R.K., Paulson D.F. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1993, 71:3993-4001.
6. Levesque P., Ramchurren N., Saini K., Joyce A., Libertino J., Summerhayes I.C. Screening of human bladder tumors and urine sediments for the presence of HRAS mutations. Int J Cancer 1993, 55:785-790.
7. Bonner R.B., Hemstreet G.P., Fradet Y., Rao J.Y., Min K.W., Hurst R.E. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells. Cancer 1993, 72:2461-2469.
8. Boulalas I., Zaravinos A., Karyotis I., Delakas D., Spandidos D.A. Activation of RAS family genes in urothelial carcinoma. J Urol 2009, 181:2312-2319.
9. Song C., Hu C.D., Masago M., Kariyai K., Yamawaki-Kataoka Y., Shibatohge M., et al. Regulation of a novel human phospholipase C, PLCε, through membrane targeting by Ras. J Biol Chem 2001, 276:2752-2757.
10. Min/+ mice through augmentation of inflammation and angiogenesis. Carcinogenesis 2009, 30:1424-1432.
11. Wing M.R., Bourdon D.M., Harden T.K. PLC-ε: a shared effector protein in Ras-, Rho-, and Gαβγ-mediated signaling. Mol Interv 2003, 3:273-280.
12. Matsubara K., Kishida S., Matsuura Y., Kitayama H., Noda M., Kikuchi A. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. Oncogene 1999, 18:1303-1312.
13. Chen H., Chen Y., Zhang Z., Ding Y., Lin X., Zhang G., et al. Study of the mechanism of regulating effect of protein kinase C on the metastasis and invasion of large intestine carcinoma cells [In Chinese]. Practical J Cancer 2004, 19:361-364.
14. Hojilla C.V., Mohammed F.F., Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 2003, 89:1817-1821.
15. Björklund M., Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005, 1755:37-69.
16. Gerhards S., Jung K., Koenig F., Daniltchenko D., Hauptmann S., Schnorr D., et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 2001, 57:675-679.
17. Gohji K., Fujimoto N., Komiyama T., Fujii A., Ohkawa J., Kamidono S., et al. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer 1996, 78:2379-2387.
18. St-Pierre Y., Van Themsche C., Estève P.O. Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies. Curr Drug Targets Inflamm Allergy 2003, 2:206-215.
19. Kader A.K., Shao L., Dinney C.P., Schabath M.B., Wang Y., Liu J., et al. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res 2006, 66:11644-11648.
20. Miyake H., Hara I., Yamanaka K., Gohji K., Arakawa S., Kamidono S. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells. Br J Cancer 1999, 79:1651-1656.
21. Ruifa H., Liwei L., Binxin L., Ximing L. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells. Urol Int 2006, 77:355-361.
22. Bochner B.H. Gene therapy in bladder cancer. Curr Opin Urol 2008, 18:519-523.
23. Zhang T., Li X., Yu W., Yan Z., Zou H., He X. Overexpression of thymosin beta-10 inhibits VEGF mRNA expression, autocrine VEGF protein production, and tube formation in hypoxia-induced monkey choroid-retinal endothelial cells. Ophthalmic Res 2009, 41:36-43.
24. Wu D., Tadano M., Edamatsu H., Masago-Toda M., Yamawaki-Kataoka Y., Terashima T., et al. Neuronal lineage-specific induction of phospholipase C expression in the developing mouse brain. Eur J Neurosci 2003, 17:1571-1580.
25. Cross K.J., Bomsztyk E.D., Weinstein A.L., Teo E.H., Spector J.A., Lyden D.C. A novel method for targeted gene therapy in ischemic tissues through viral transfection of an expression cassette containing multiple repetitions of hypoxia response element. Plast Reconstr Surg 2009, 123(2 Suppl). 76S-82S.
26. Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000, 404:293-296.
27. Shimizu S., Kamata M., Kittipongdaja P., Chen K.N., Kim S., Pang S., et al. Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5. Genet Vaccines Ther 2009, 7:8.
28. Przybojewska B., Jagiello A., Jalmuzna P. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet Cytogenet 2000, 121:73-77.